2018 Fall Conference | C17 - Practice Management VI: Being a Provider in the Era of APMs

Date Saturday 10/27/18

Time 10:00 AM - 11:30 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Brad C. Klein, MD, MBA, FAAN

Topic(s) Practice, Policy, and Ethics

Learning Objectives Upon completion of this program, participants should have an understanding of an APM, the essential components that are needed to implement and successfully deliver care in an APM, and review the risks/rewards of this payment approach for their organization.

CME Available 1.50 CME credits

Core Competencies Patient Care & Procedural Skills, Professionalism, Practice-based Learning and Improvement

Program Tracks Business of Neurology

Recommended Audience Practitioner, Fellow, Resident, Other, Trainee, General Neurologist, Specialist Neurologist, Advanced Practice Provider

Teaching Styles Didactic

Program Materials

Event Timeline
10:00 AM - 10:40 AM	Speaker	APM’s from the Payer Perspective Robert M. Kropp, MD, FAAN
10:40 AM - 11:20 AM	Speaker	Infrastructure and Care Delivery Essentials for APM Success David A. Evans, MBA
11:20 AM - 11:30 AM	Q&A	Questions and Answers

Faculty Disclosures
Brad C. Klein, MD, MBA, FAAN	Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly and Company. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AbbVie. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Scilex. The institution of Dr. Klein has received research support from AbbVie. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Shareholder with AppsbyDocs, LLC. Dr. Klein has a non-compensated relationship as a Chair, Practice Management Committee with American Headache Society that is relevant to AAN interests or activities.
David A. Evans, MBA	Mr. Evans has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon Therapeutics/Amgen. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Averitas . Mr. Evans has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eli Lilly. Mr. Evans has stock in NeuroNet GPO. Mr. Evans has stock in NeuroNet Pro. Mr. Evans has stock in NeuroDiscovery.AI.
Robert M. Kropp, MD, FAAN	Dr. Kropp has stock in RxLive, LLC. Dr. Kropp has a non-compensated relationship as a Investor with RxLive that is relevant to AAN interests or activities.

��ɫ��

��ɫ��